Differentiated approach at the choice of chronic hepatitis C antiviral therapy mode (real clinical practice experience)

Differentiated approach at the choice of chronic hepatitis C antiviral therapy mode (real clinical practice experience)

Aim of the study. To estimate efficacy and safety of cepeginterferon-alpha 2b (cPEG-IFNα2b) and ribavirin combination for the treatment of chronic hepatitis C (CHC), to define necessity of IL-28V genetic polymorphism diagnostics, to estimate liver elastometry scores at the background of antiviral th...

Full description

Saved in:

Bibliographic Details
Main Authors:	I. Yu. Pirogova, N. B. Kovaleva, E. P. Patlusov, E. S. Radchenko
Format:	Article
Language:	Russian
Published:	Gastro LLC 2018-08-01
Series:	Российский журнал гастроэнтерологии, гепатологии, колопроктологии
Subjects:	хронический гепатит с противовирусная терапия цепэгинтерферон альфа 2b полиморфизм гена ил-28в
Online Access:	https://www.gastro-j.ru/jour/article/view/216
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

The modern options of chronic hepatitis C antiviral therapy with daclatasvir: results of named patient program
by: V. T. Ivashkin, et al.
Published: (2018-08-01)

Efficacy and safety of the Russian protease inhibitor narlaprevir at treatment-naive and earlier treated noncirrhotic patients with the 1st genotype chronic hepatitis C (PIONEER study)
by: M. V. Mayevskaya, et al.
Published: (2018-08-01)

Clinical role of endothelial dysfunction and hemostasis gene allelic variants in hepatitis C virus-associated cryoglobulinemia
by: M. V. Sokolova, et al.
Published: (2018-08-01)

The clinical role of blood coagulation and platelet receptors gene allelic variants in development of cryoglobulinemic vasculitis at chronic hepatitis C
by: Yekaterina Ye. Starostina, et al.
Published: (2018-08-01)

The issue of clinical application of non-invasive evaluation of liver fibrosis at chronic hepatitis B
by: Chavdar S. Pavlov, et al.
Published: (2016-08-01)

Pegilated interferon alpha 2b «Pegaltevir» chronic hepatitis C treatment (randomized clinical trial)
by: Marina V. Mayevskaya, et al.
Published: (2018-08-01)

Efficacy of daclatasvir and asunaprevir for viral hepatitis С in two donor lung recipients
by: D. T. Abdurakhmanov, et al.
Published: (2018-08-01)

Interleukin 28B polymorphism impact on early HCV kinetics in HCV-infected liver transplant recipients undergoing antiviral therapy
by: V. E. Syutkin, et al.
Published: (2011-12-01)

Efficacy and safety of 3D-therapy at HCV-related subcompensated liver cirrhosis (genotype 1b)
by: P. O. Bogomolov, et al.
Published: (2018-08-01)

Infusion therapy for chronic liver diseases
by: I. A. Kurkina, et al.
Published: (2018-08-01)

Diagnostics and treatment of Helicobacter pylori infection in adults: Clinical guidelines of the Russian gastroenterological association
by: V. T. Ivashkin, et al.
Published: (2018-08-01)

Seronegative autoimmune hepatitis
by: A. O. Buyeverov
Published: (2018-08-01)

Hexapeptide dalargin in clinical gastroenterology: 30 years' of clinical application of the drug
by: S. A. Bulgakov
Published: (2016-08-01)

The algorythm of viral hepatites B and C diagnostics and treatment
by: N. D. Yuschuk, et al.
Published: (2010-12-01)

Role of Interleukin-28B in clearance of HCV in acute and chronic hepatitis patients in Kirkuk city
by: Muhannad Abdullah Alazzawy
Published: (2018-07-01)

Helicobacter pylori infection diagnostics and choice of eradication treatment: results of inquiry of doctors from different regions of Russian Federation
by: N. N. Dekhnich, et al.
Published: (2018-08-01)

The impact of genetic polymorphisms of IL28B gene on the efficacy of antiviral therapy of the chronic hepatitis C by using the standard Interferon-<i>α</i>
by: A. V. Lapshin, et al.
Published: (2013-03-01)

Carbohydrate intolerance
by: V. O. Kaybysheva, et al.
Published: (2018-08-01)

Morphological features of chronic virus-associated gastritis and duodenitis
by: S. Yu. Yermak, et al.
Published: (2018-08-01)

HВcorAg expression in HВeАg-negative hepatitis: correlation to clinical and histological activity and HВsAg-status
by: O. P. Dudanova, et al.
Published: (2012-04-01)

Treatment of end-stages of liver disease in outcome of persistent hepatitis C virus infection at deficiency of donor organs
by: Ye. N. German, et al.
Published: (2011-03-01)

Population features of prevalence and clinical-diagnostic role of NOD2 gene polymorphisms associated with Crohn’s disease
by: D. A. Kuznetsova, et al.
Published: (2018-08-01)

The clinical role of blood coagulation and platelet receptors gene allelic variants in development of Wilson’s disease
by: T. P. Rozina, et al.
Published: (2018-08-01)

Гиповолемический шок у взрослых. Клинические рекомендации Общероссийской общественной организации «Федерация анестезиологов и реаниматологов»
by: Игорь Борисович Заболотских, et al.
Published: (2024-11-01)

Влияние курсового приема L-орнитин- L-аспартата на фиброз и стеатоз печени у больных ассоциированной с нарушениями метаболизма жировой болезнью печени (неалкогольной жировой болезнью печени), имеющих гипераммониемию
by: Е. V. Garanina
Published: (2021-12-01)

The role of polymorphism (rs1800566) of NAD(F)H quinone oxidoreductase-1 in development of acute pancreatitis
by: T. A. Samgina, et al.
Published: (2018-08-01)

Hepatic encephalopathy: pathogenesis, clinical presentation, diagnostics, treatment
by: Ch. S. Pavlov, et al.
Published: (2016-08-01)

Diagnostics and treatment of exocrine pancreatic insufficiency: clinical guidelines of the Russian gastroenterological Association
by: V. T. Ivashkin, et al.
Published: (2018-08-01)

Diagnostics and treatment of pancreatic exocrine insufficiency: clinical guidelines of the Russian gastroenterological association
by: V. T. Ivashkin, et al.
Published: (2018-08-01)

Эффективность алгоритма назначения диуретической терапии под контролем натрийуреза у пациентов с острой декомпенсацией сердечной недостаточности в отделении реанимации и интенсивной терапии: проспективное интервенционное контролируемое исследование
by: Жанна Давидовна Кобалава, et al.
Published: (2024-11-01)

#CHOOSETOCHALLENGE: COVID-19, COMMUNITY RESEARCH, AND THE CANAANITE WOMAN
by: M. Ibita, et al.
Published: (2023-04-01)

Post-chemoradiotherapy adjuvant chemotherapy of rectal cancer
by: E. V. Ledin, et al.
Published: (2018-08-01)

Treatment of Helicobacter pylori infection: mainstream and innovations (Review of the literature and Russian gastroenterological association Advisory council resolution, May 19, 2017)
by: V. T. Ivashkin, et al.
Published: (2018-08-01)

The role of cytokine genetic polymorphism in development of acute pancreatitis: analysis of intergenic and environmental interactions
by: T. A. Samgina, et al.
Published: (2018-08-01)

Primary liver lymphoma: review of the literature and clinical case presentation
by: A. K. Smolyaninova, et al.
Published: (2018-08-01)

Antiviral therapy and regression of liver fibrosis at chronic hepatitis B
by: D. T. Abdurakhmanov
Published: (2010-02-01)

Clinical significance of Helicobacter pylori infection in iron-deficiency anemia: features of comprehensive treatment approach
by: I. V. Mayev, et al.
Published: (2016-08-01)

Modern modes of chronic hepatitis C treatment
by: V. T. Ivashkin, et al.
Published: (2012-02-01)

Procalcitonin and C-reactive protein - early predictors of low colorectal anastomotic leakage
by: Yu. A. Shelygin, et al.
Published: (2018-08-01)

Antiviral therapy for chronic hepatitis C: is there a time to change existing standards?
by: D. T. Abdurakhmanov
Published: (2009-02-01)